Protollin

 

Topic mentions per year

Topic mentions per year

2004-2017
01220042017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
An inactivated, mucosal mumps virus (MuV) vaccine would address many of the problems associated with current live-attenuated… (More)
Is this relevant?
2012
2012
Influenza A/H3N2 viruses have caused the most severe epidemics since 1968 despite current immunization programs with inactivated… (More)
Is this relevant?
2009
2009
BACKGROUND Immunization of mice with the G protein of respiratory syncytial virus (RSV) characteristically induces an immune… (More)
Is this relevant?
2009
2009
An intranasal vaccine composed of Toll-like receptor 2 (TLR2) ligand Neisseria meningitidis outer membrane proteins and Toll-like… (More)
Is this relevant?
2008
2008
OBJECTIVE We assessed whether peripheral activation of microglia by a nasal proteosome-based adjuvant (Protollin) that has been… (More)
Is this relevant?
2007
2007
The protective efficacy of an intranasal (IN) Protollin-eRSV vaccine has recently been demonstrated in the RSV-susceptible BALB/c… (More)
Is this relevant?
2007
2007
The feasibility of developing a prophylactic vaccine against SARS was assessed by comparing the immune responses elicited by… (More)
Is this relevant?
2006
2006
F1-V is a recombinant plague antigen comprising the capsular (F1) and virulence-associated (V) proteins. Given intramuscularly… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2005
2005
Protollin-MV is a vaccine produced by mixing split measles virus (MV) antigen with the novel adjuvant Protollin (Neisseria… (More)
Is this relevant?
2004
2004
Protollin is a novel adjuvant comprising Proteosomes non-covalently complexed with LPS. Intranasal immunization of mice with… (More)
Is this relevant?